Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Advances in Nutrition · 2025-01 · 16 (1) · 100327
DOI: 10.1016/j.advnut.2024.100327 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Advances in Nutrition, 2025-01. Verfasst von Gabrielle Viscardi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Toronto 3D Knowledge Synthesis and …. Hauptthemen laut MEDLINE: Isoflavones, Glycine max, Soy Foods, Postmenopause. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, United Soybean Board, Ontario Ministry of Research and Innovation.
Abstract (Originalsprache)
Despite recommendations to increase plant food consumption for public and planetary health and the role that soy foods can play in plant-predominant diets, controversies around the effects of soy foods, especially soy isoflavones, are a barrier to their intake. Given their cardioprotective effects and ability to alleviate menopausal symptoms, addressing these concerns is particularly relevant to women. This systematic review and meta-analysis of randomized controlled trials aimed to determine the effect of soy isoflavones on measures of estrogenicity in postmenopausal women. MEDLINE, Embase, and Cochrane Library were searched through August 2024 for randomized trials ≥3-mo investigating soy isoflavones compared with non-isoflavone controls in postmenopausal women. Outcomes included endometrial thickness (ET), vaginal maturation index (VMI), follicle-stimulating hormone (FSH), and estradiol. Independent authors extracted data and assessed risk of bias. Grading of Recommendations, Assessment, Development and Evaluation was used to assess certainty of evidence. We included 40 trials (52 trial comparisons, n = 3285) assessing the effect of a median reported dose of 75 mg/d of soy isoflavones in substitution for non-isoflavone controls over a median of 24 wk. Soy isoflavones had no statistically significant effect on any measure of estrogenicity; ET [mean difference, -0.22 mm (95% confidence interval, -0.45, 0.01 mm), PMD = 0.059], VMI [2.31 (-2.14, 6.75), PMD = 0.310], FSH [-0.02 IU/L (-2.39, 2.35 IU/L), PMD = 0.987], and estradiol [1.61 pmol/L (-1.17, 4.38 pmol/L), PMD = 0.256]. The certainty of evidence was high to moderate for all outcomes. Current evidence suggests that soy isoflavones do not exhibit estrogenic effects compared with non-isoflavone controls on 4 measures of estrogenicity in postmenopausal women. This synthesis supports that soy isoflavones likely act as selective estrogen receptor modulators, differing clinically from the hormone estrogen. Addressing public health concerns may promote soy foods as high-quality plant protein sources with low environmental impact and cost, particularly benefiting postmenopausal women and aligning with sustainable dietary patterns and guidelines. This study was registered in PROSPERO as CRD42023439239.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification…
- Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Department of Gynecology, Women's College Hospital, Toronto, Ontario, Canada; Department of Obstetrics and Gynaecology, Mount Sinai Hospital (Toronto), Sinai Health, Toronto, Ontario, Canada; Department of Obstetrics &…
- Soy Nutrition Institute Global, Washington, DC, United States.
Förderung
- Canadian Institutes of Health Research
- United Soybean Board
- Ontario Ministry of Research and Innovation
Zitieren
APA
Viscardi, G., Back, S., Ahmed, A., Yang, S., Mejia, S. B., Zurbau, A., Khan, T. A., Selk, A., Messina, M., Kendall, C. W., Jenkins, D. J., Sievenpiper, J. L., & Chiavaroli, L. (2025). Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition, 16(1), 100327. https://doi.org/10.1016/j.advnut.2024.100327
Vancouver
Viscardi G, Back S, Ahmed A, Yang S, Mejia SB, Zurbau A, et al. Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition. 2025;16(1):100327. doi:10.1016/j.advnut.2024.100327
BibTeX
@article{Viscardi2025,
author = {Viscardi, Gabrielle and Back, Songhee and Ahmed, Amna and Yang, Shuting and Mejia, Sonia Blanco and Zurbau, Andreea and Khan, Tauseef A and Selk, Amanda and Messina, Mark and Kendall, Cyril Wc and Jenkins, David Ja and Sievenpiper, John L and Chiavaroli, Laura},
title = {Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
journal = {Advances in Nutrition},
year = {2025},
volume = {16},
number = {1},
pages = {100327},
doi = {10.1016/j.advnut.2024.100327}
}
EUVIMED